Vaccine Management Law

On:
In: Law, Medicine/medical devices
On June 30, the Vaccine Management Law was formally passed and shall be implemented on December 1, 2019. The Law on Vaccine Management clearly stipulates that vaccines are strategic and public welfare products of the country. It clearly puts forward the strictest supervision over the whole process of vaccine development, production, circulation and vaccination, including research and development management, production access management, process control, circulation and distribution control and penalty measures. Development and management includes biosafety control during the development process and requirements for bacterial strain and cell strain management. Vaccine clinical trials should be organized and implemented by medicalRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field

Related posts:

  1. NMPA:Regulations on vaccine production and circulation
  2. Management requirements for drug record and data-Trial
  3. New Good Manufacture Practice for biological products
  4. China will establish data security management certification
  5. Rules for the Management of Scrapped Vehicles Recycling
  6. Measures for batch issuance of biological products
  7. NMPA issued 5 drug traceability standards
  8. Drug Administration Law
  9. China subsides demonstration program of fuel cell vehicles
  10. Industrial Energy-saving Diagnostic Service Action